These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11773481)

  • 41. [Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results].
    Neumann K; Pudszuhn A; Welzel C; Bartel-Friedrich S; Passmann M
    Laryngorhinootologie; 2003 Oct; 82(10):700-6. PubMed ID: 14593568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phase I study of combination therapy with intravenous cidofovir and oral ganciclovir for cytomegalovirus retinitis in patients with AIDS.
    Jacobson MA; Wilson S; Stanley H; Holtzer C; Cherrington J; Safrin S
    Clin Infect Dis; 1999 Mar; 28(3):528-33. PubMed ID: 10194072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects.
    Wachsman M; Petty BG; Cundy KC; Jaffe HS; Fisher PE; Pastelak A; Lietman PS
    Antiviral Res; 1996 Mar; 29(2-3):153-61. PubMed ID: 8739595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue.
    Bidanset DJ; Rybak RJ; Hartline CB; Kern ER
    Antiviral Res; 2004 Jul; 63(1):61-4. PubMed ID: 15196821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient.
    Bjorang O; Tveitan H; Midtvedt K; Broch LU; Scott H; Andresen PA
    Nephrol Dial Transplant; 2002 Nov; 17(11):2023-5. PubMed ID: 12401867
    [No Abstract]   [Full Text] [Related]  

  • 46. Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir.
    Pransky SM; Albright JT; Magit AE
    Laryngoscope; 2003 Sep; 113(9):1583-7. PubMed ID: 12972938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Successful resolution of progressive multifocal leukoencephalopathy after combination therapy with cidofovir and cytosine arabinoside.
    Blick G; Whiteside M; Griegor P; Hopkins U; Garton T; LaGravinese L
    Clin Infect Dis; 1998 Jan; 26(1):191-2. PubMed ID: 9455537
    [No Abstract]   [Full Text] [Related]  

  • 48. Efficacy of cidofovir in the treatment of recalcitrant molluscum contagiosum in an AIDS patient.
    Ibarra V; Blanco JR; Oteo JA; Rosel L
    Acta Derm Venereol; 2000; 80(4):315-6. PubMed ID: 11028878
    [No Abstract]   [Full Text] [Related]  

  • 49. Successful treatment of recalcitrant condyloma with topical cidofovir.
    Hengge UR; Tietze G
    Sex Transm Infect; 2000 Apr; 76(2):143. PubMed ID: 10858720
    [No Abstract]   [Full Text] [Related]  

  • 50. Renal Toxicity in Pediatric Patients Receiving Cidofovir for the Treatment of Adenovirus Infection.
    Vora SB; Brothers AW; Englund JA
    J Pediatric Infect Dis Soc; 2017 Nov; 6(4):399-402. PubMed ID: 28419263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
    Chakrabarti S; Collingham KE; Osman H; Fegan CD; Milligan DW
    Bone Marrow Transplant; 2001 Nov; 28(9):879-81. PubMed ID: 11781649
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stability of cidofovir in 0.9% sodium chloride injection for five days.
    Ennis RD; Dahl TC
    Am J Health Syst Pharm; 1997 Oct; 54(19):2204-6. PubMed ID: 9331442
    [No Abstract]   [Full Text] [Related]  

  • 53. Anti-HIV agents at ICAAC.
    Smart T
    GMHC Treat Issues; 1996 Oct; 10(10):7-10. PubMed ID: 11364007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BK transplant nephropathy successfully treated with cidofovir.
    Keller LS; Peh CA; Nolan J; Bannister KM; Clarkson AR; Faull RJ
    Nephrol Dial Transplant; 2003 May; 18(5):1013-4. PubMed ID: 12686681
    [No Abstract]   [Full Text] [Related]  

  • 55. Abatement of cutaneous Kaposi's sarcoma associated with cidofovir treatment.
    Hammoud Z; Parenti DM; Simon GL
    Clin Infect Dis; 1998 May; 26(5):1233. PubMed ID: 9597261
    [No Abstract]   [Full Text] [Related]  

  • 56. Abatement of cutaneous Kaposi's sarcoma associated with cidofovir treatment.
    Simonart T; Noel JC; De Clercq E; Snoeck R
    Clin Infect Dis; 1998 Dec; 27(6):1562. PubMed ID: 9868698
    [No Abstract]   [Full Text] [Related]  

  • 57. Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS.
    Lee TA; Sullivan SD; Veenstra DL; Ramsey SD; Steger PJ; Malinverni R; Pleil AM; Williamson T
    Pharmacoeconomics; 2001; 19(5 Pt 2):535-50. PubMed ID: 11465299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Bilateral uveitis with definitive hypotony caused by systemic cidofovir].
    Rapp P; Pilon F; Chiambaretta F; Ménérath JM; Jacomet C
    J Fr Ophtalmol; 2003 Sep; 26(7):717-9. PubMed ID: 13130259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cidofovir may be deleterious in BK virus-associated nephropathy.
    Hakeem A; Sharma H; Sharma A
    Transplantation; 2011 Jan; 91(2):e11-2; author reply e12. PubMed ID: 21239956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.